168 related articles for article (PubMed ID: 26108658)
1. VB-111: a novel anti-vascular therapeutic for glioblastoma multiforme.
Gruslova A; Cavazos DA; Miller JR; Breitbart E; Cohen YC; Bangio L; Yakov N; Soundararajan A; Floyd JR; Brenner AJ
J Neurooncol; 2015 Sep; 124(3):365-72. PubMed ID: 26108658
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic and anti-invasive effects of sunitinib on experimental human glioblastoma.
de Boüard S; Herlin P; Christensen JG; Lemoisson E; Gauduchon P; Raymond E; Guillamo JS
Neuro Oncol; 2007 Oct; 9(4):412-23. PubMed ID: 17622648
[TBL] [Abstract][Full Text] [Related]
3. Combined acetyl-11-keto-β-boswellic acid and radiation treatment inhibited glioblastoma tumor cells.
Conti S; Vexler A; Edry-Botzer L; Kalich-Philosoph L; Corn BW; Shtraus N; Meir Y; Hagoel L; Shtabsky A; Marmor S; Earon G; Lev-Ari S
PLoS One; 2018; 13(7):e0198627. PubMed ID: 29969452
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated delivery of CALR and MAGE-A3 inhibits invasion and angiogenesis of glioblastoma cell line U87.
Liu XL; Zhao D; Sun DP; Wang Y; Li Y; Qiu FQ; Ma P
J Exp Clin Cancer Res; 2012 Feb; 31(1):8. PubMed ID: 22293781
[TBL] [Abstract][Full Text] [Related]
5. Phase I dose-escalation study of VB-111, an antiangiogenic virotherapy, in patients with advanced solid tumors.
Brenner AJ; Cohen YC; Breitbart E; Bangio L; Sarantopoulos J; Giles FJ; Borden EC; Harats D; Triozzi PL
Clin Cancer Res; 2013 Jul; 19(14):3996-4007. PubMed ID: 23589178
[TBL] [Abstract][Full Text] [Related]
6. Immunohistopathological and neuroimaging characterization of murine orthotopic xenograft models of glioblastoma multiforme recapitulating the most salient features of human disease.
Radaelli E; Ceruti R; Patton V; Russo M; Degrassi A; Croci V; Caprera F; Stortini G; Scanziani E; Pesenti E; Alzani R
Histol Histopathol; 2009 Jul; 24(7):879-91. PubMed ID: 19475534
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic therapy by local intracerebral microinfusion improves treatment efficiency and survival in an orthotopic human glioblastoma model.
Schmidt NO; Ziu M; Carrabba G; Giussani C; Bello L; Sun Y; Schmidt K; Albert M; Black PM; Carroll RS
Clin Cancer Res; 2004 Feb; 10(4):1255-62. PubMed ID: 14977823
[TBL] [Abstract][Full Text] [Related]
8. Successful inhibition of intracranial human glioblastoma multiforme xenograft growth via systemic adenoviral delivery of soluble endostatin and soluble vascular endothelial growth factor receptor-2: laboratory investigation.
Szentirmai O; Baker CH; Bullain SS; Lin N; Takahashi M; Folkman J; Mulligan RC; Carter BS
J Neurosurg; 2008 May; 108(5):979-88. PubMed ID: 18447716
[TBL] [Abstract][Full Text] [Related]
9. Dual antivascular function of human fibulin-3 variant, a potential new drug discovery strategy for glioblastoma.
Ke C; Luo JR; Cen ZW; Li Y; Cai HP; Wang J; Chen FR; Siegel ER; Le KN; Winokan JR; Gibson GJ; McSwain AE; Afrasiabi K; Linskey ME; Zhou YX; Chen ZP; Zhou YH
Cancer Sci; 2020 Mar; 111(3):940-950. PubMed ID: 31922633
[TBL] [Abstract][Full Text] [Related]
10. Flt3L and TK gene therapy eradicate multifocal glioma in a syngeneic glioblastoma model.
King GD; Muhammad AK; Curtin JF; Barcia C; Puntel M; Liu C; Honig SB; Candolfi M; Mondkar S; Lowenstein PR; Castro MG
Neuro Oncol; 2008 Feb; 10(1):19-31. PubMed ID: 18079358
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor-2-retargeted adenoviral vector for selective transduction of primary glioblastoma multiforme endothelial cells.
Gupta V; Wang W; Sosnowski BA; Hofman FM; Chen TC
Neurosurg Focus; 2006 Apr; 20(4):E26. PubMed ID: 16709032
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide.
Takahashi N; Haba A; Matsuno F; Seon BK
Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802
[TBL] [Abstract][Full Text] [Related]
13. Bisdemethoxycurcumin Induces Cell Apoptosis and Inhibits Human Brain Glioblastoma GBM 8401/
Hsia TC; Peng SF; Chueh FS; Lu KW; Yang JL; Huang AC; Hsu FT; Wu RS
Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008959
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral decorin gene delivery by AAV vector inhibits brain glioblastomas and prolongs survival of animals by inducing cell differentiation.
Ma HI; Hueng DY; Shui HA; Han JM; Wang CH; Lai YH; Cheng SY; Xiao X; Chen MT; Yang YP
Int J Mol Sci; 2014 Mar; 15(3):4393-414. PubMed ID: 24625664
[TBL] [Abstract][Full Text] [Related]
15. Preclinical evaluation of tumor microvascular response to a novel antiangiogenic/antitumor agent RO0281501 by dynamic contrast-enhanced MRI at 1.5 T.
Muruganandham M; Lupu M; Dyke JP; Matei C; Linn M; Packman K; Kolinsky K; Higgins B; Koutcher JA
Mol Cancer Ther; 2006 Aug; 5(8):1950-7. PubMed ID: 16928815
[TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic activity of BAI1 in vivo: implications for gene therapy of human glioblastomas.
Kang X; Xiao X; Harata M; Bai Y; Nakazaki Y; Soda Y; Kurita R; Tanaka T; Komine F; Izawa K; Kunisaki R; Setoyama M; Nishimori H; Natsume A; Sunamura M; Lozonshi L; Saitoh I; Tokino T; Asano S; Nakamura Y; Tani K
Cancer Gene Ther; 2006 Apr; 13(4):385-92. PubMed ID: 16244591
[TBL] [Abstract][Full Text] [Related]
17. Real-time multi-modality imaging of glioblastoma tumor resection and recurrence.
Hingtgen S; Figueiredo JL; Farrar C; Duebgen M; Martinez-Quintanilla J; Bhere D; Shah K
J Neurooncol; 2013 Jan; 111(2):153-61. PubMed ID: 23242736
[TBL] [Abstract][Full Text] [Related]
18. Combinatorial antiangiogenic gene therapy by nonviral gene transfer using the sleeping beauty transposon causes tumor regression and improves survival in mice bearing intracranial human glioblastoma.
Ohlfest JR; Demorest ZL; Motooka Y; Vengco I; Oh S; Chen E; Scappaticci FA; Saplis RJ; Ekker SC; Low WC; Freese AB; Largaespada DA
Mol Ther; 2005 Nov; 12(5):778-88. PubMed ID: 16150649
[TBL] [Abstract][Full Text] [Related]
19. Trimodal glioblastoma treatment consisting of concurrent radiotherapy, temozolomide, and the novel TGF-β receptor I kinase inhibitor LY2109761.
Zhang M; Herion TW; Timke C; Han N; Hauser K; Weber KJ; Peschke P; Wirkner U; Lahn M; Huber PE
Neoplasia; 2011 Jun; 13(6):537-49. PubMed ID: 21677877
[TBL] [Abstract][Full Text] [Related]
20. A plasmid-encoded VEGF siRNA reduces glioblastoma angiogenesis and its combination with interleukin-4 blocks tumor growth in a xenograft mouse model.
Niola F; Evangelisti C; Campagnolo L; Massalini S; Buè MC; Mangiola A; Masotti A; Maira G; Farace MG; Ciafrè SA
Cancer Biol Ther; 2006 Feb; 5(2):174-9. PubMed ID: 16340308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
